NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma

NCT02093000

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Lung Adenocarcinoma

Interventions: Bevacizumab

Countries: Hungary

This prospective, open-label, single arm, non-interventional study will investigate the effectiveness of bevacizumab monotherapy in participants with lung adenocarcinoma who previously received 4 to 6 cycles of induction platinum doublet plus bevacizumab.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Participant who previously received 4 to 6 cycles of induction platinum doublet plus bevacizumab
* Participant who received only 1 cycle of bevacizumab maintenance treatment
* Meet summary of product characteristics guidelines

Exclusion Criteria:

* Participant who received the first cycle of maintenance bevacizumab more than 4 weeks after the postinduction tumor assessment
* Pregnant or breast-feeding

Locations (16)

Budapest, Hungary
Budapest, Hungary
Budapest, Hungary
Debrecen, Hungary
Deszk, Hungary
Farkasgyepű, Hungary
Győr, Hungary
Gyula, Hungary
Kecskemét, Hungary
Mátraháza, Hungary
Nyíregyháza, Hungary
Pécs, Hungary
Székesfehérvár, Hungary
Szombathely, Hungary
Tatabánya, Hungary
Törökbálint, Hungary